Literature DB >> 1541972

Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.

A Demaine1, N Willcox, M Janer, K Welsh, J Newsom-Davis.   

Abstract

Susceptibility to myasthenia gravis (MG) is known to involve genes residing in the major histocompatibility complex class I and II regions (HLA-B8 and DR3). Immunoglobulin heavy chain constant region (IgCH) allotypes have also shown some associations with MG. We have used restriction fragment length polymorphism analysis with probes to the IgCH switch (S) regions mu and alpha 1 and the downstream marker D14S1 to investigate 189 Caucasoid patients with well-defined MG. A highly significant increase in the frequency of the 2.6 kilobase (kb) S mu homozygous genotype and the 2.6 kb S mu allele was found in patients with disease onset after the age of 40 years (late onset) compared with normal controls (P less than 0.00075 and P less than 0.025 respectively). No association was found at the S alpha 1 or D14S1 loci. In patients with an associated thymoma there was a moderate increase in the frequency of the 2.6 kb S mu and 7.4 kb S alpha 1 genotypes. These results independently support the previous separation of the late-onset subgroup. Finally, the stronger association at S mu rather than at the downstream S alpha 1, Gm and D14S1 loci suggest that the genes predisposing to MG are located within the variable region of the Ig heavy chain loci.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541972     DOI: 10.1007/bf00839214

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Immunoglobulin allotypes in myasthenia gravis patients with a thymoma.

Authors:  N E Gilhus; J P Pandey; P I Gaarder; J A Aarli
Journal:  J Autoimmun       Date:  1990-06       Impact factor: 7.094

2.  Arthritis in patients with psoriasis is associated with an immunoglobulin gene polymorphism.

Authors:  L I Sakkas; A G Demaine; G S Panayi; K I Welsh
Journal:  Arthritis Rheum       Date:  1988-02

3.  Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region.

Authors:  A G Demaine; M Rambausek; J F Knight; D G Williams; K I Welsh; E Ritz
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

7.  A highly polymorphic locus in human DNA.

Authors:  A R Wyman; R White
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease.

Authors:  A G Demaine; D H Taube; R W Vaughan; L A Kerr; K I Welsh
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

9.  Gm allotypes in Swedish myasthenia gravis patients.

Authors:  C I Smith; R Grubb; L Hammarström; G Matell
Journal:  J Immunogenet       Date:  1983-02

10.  Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man.

Authors:  N Migone; J Feder; H Cann; B van West; J Hwang; N Takahashi; T Honjo; A Piazza; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  3 in total

1.  Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.

Authors:  C W Zimmermann; F Eblen
Journal:  Clin Investig       Date:  1993-06

2.  beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG).

Authors:  B Y Xu; D Huang; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis.

Authors:  H J Garchon; F Djabiri; J P Viard; P Gajdos; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.